Articles Tagged With: transparency
-
Does Current IRB System Ensure Ethical Research?
A consensus is needed for how to measure IRB quality or effectiveness, and more inspections are needed to ensure instances of IRB noncompliance are identified, according to the authors of a recent report.
-
Plan Now for Eventual HIPAA Changes
HHS has been expected to finalize proposed modifications to HIPAA in 2023, but it now appears that will not happen until December 2024 — or later. Whenever the changes come, covered entities will need to review their compliance policies and update them within 180 days of final rulemaking.
-
Lack of Transparency on Informed Consent Documents Complicates Oncology Trials
Researchers should describe the potential benefits and risks of participating in the trial compared with potential benefits and risks of receiving standard treatment outside the trial. Also, strive to write consent forms that highlight the key issues involved in the decision to join a trial.
-
Inconsistent Transparency on Physician Sexual Misconduct Allegations
Medical boards are not consistently transparent on physician sexual misconduct, even two years after the Federation of State Medical Boards released a policy calling for such.
-
More Transparency Might Bolster Trust in FDA Advisory Committees
The FDA does not always convene an advisory committee meeting in connection with application reviews, but may do so when questions related to safety or the data submitted to support approval arise. In the modern environment, some believe if they cannot see it, foul play must be afoot. Some of that could be allayed by transparency and more public education.
-
Research Shows How Teamwork Changed During the COVID-19 Pandemic
The COVID-19 crisis response relied on interprofessional teamwork. But for care coordinators and pharmacists, the team experience during the pandemic was far from optimal, according to a recent study.
-
Financial Conflicts Reported Inconsistently
It might be time to consider another approach to transparency on financial conflicts.
-
For Individualized Therapy Trials, Remain Mindful of Transparency, Reporting Bias
Individualized therapy studies should be publicly and prospectively registered in a clinical trial database. The authors should report results regardless of outcomes. If these trials are not handled right, it might be a step backward in terms of transparency and reporting bias.
-
Failure to Perform Sterilization Leads to Unwanted Pregnancy, Litigation
This case presents lessons about consent, notice, and records issues as well as interesting aspects of damages for this rather unique malpractice action. This case is a twist on consent and notice whereby the patient wanted a procedure, requested it, paid for it, and believed she received it. -
Industry Payments to Surgeons Increased Despite Transparency Requirements
Despite the fact data on industry payments are publicly available, it does not appear to be causing patients to be suspicious of doctors’ integrity. To many patients, the transparency over financial ties suggests the physician is straightforward and can be trusted. Patients generally do not focus on the potentially problematic implications of clinicians accepting payments from industry.